An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

Congenital heart block, sometimes referred to as cardiac neonatal lupus, is a rare but potentially life-threatening condition ...

Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...

Boston achieved a 22.4% growth in its cardiovascular business in Q3, continuing the segment’s growth trend in 2025 due to the ...

Funded entirely by taxpayer dollars, this first-of-its-kind drug targets cellular metabolism to promote tissue repair of ...

A common arthritis drug could boost heart attack recovery and help prevent lasting, life-threatening damage to the organ, ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

A review panel found several lapses, shortcomings and miscommunication between the various agencies handling the case.

Obesity is a major public health and economic challenge in the US, costing the health care system an estimated $173 billion ...

While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious ...

MONDAY, Oct. 6, 2025 (HealthDay News) — A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the most severe form of high blood pressure, ...